Insmed | INSM - Umlaufvermögen





Umlaufvermögen Veränderung Datum
BioMarin Pharmaceutical USD 3.92B 50.99M 2026-09
Cytokinetics USD 1.19B 21.34M 2026-09
DBV Technologies USD 189.6M 12.3M 2026-09
Gilead Sciences USD 16.55B 4.02B 2026-09
Heron Therapeutics USD 229.84M 861K 2026-06
Insmed USD 1.71B 72.59M 2026-09
Novartis USD 28.75B 2.14B 2026-09
Regeneron Pharmaceuticals USD 20.8B 2.35B 2026-09
Sarepta Therapeutics USD 2.27B 49.06M 2026-09
Ultragenyx Pharmaceutical USD 544M 62M 2026-09
Vertex Pharmaceuticals USD 11.69B 857.4M 2026-09